Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Traditional risk factors of acute coronary syndrome in four different male populations - total cholesterol value does not seem to be relevant risk factor

JA. Hubacek, V. Stanek, M. Gebauerova, V. Adamkova, V. Lesauskaite, D. Zaliaduonyte-Peksiene, A. Tamosiunas, A. Supiyev, A. Kossumov, A. Zhumadilova, J. Pitha

. 2017 ; 66 (Supplementum 1) : S121-S128. [pub] 2017Apr05
. 2017 ; () : S121-S128.

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc19030525

Cardiovascular diseases are the most common cause of mortality and morbidity in most populations. As the traditional modifiable risk factors (smoking, hypertension, dyslipidemia, diabetes mellitus, and obesity) were defined decades ago, we decided to analyze recent data in patients who survived acute coronary syndrome (ACS). The Czech part of the study included data from 999 males, and compared them with the post-MONICA study (1,259 males, representing general population). The Lithuanian study included 479 male patients and 456 age-matched controls. The Kazakhstan part included 232 patients and 413 controls. In two countries, the most robust ACS risk factor was smoking (OR 3.85 in the Czech study and 5.76 in the Lithuanian study), followed by diabetes (OR 2.26 and 2.07) and hypertension (moderate risk elevation with OR 1.43 and 1.49). These factors did not influence the ACS risk in Kazakhstan. BMI had no significant effect on ACS and plasma cholesterol was surprisingly significantly lower (P<0.001) in patients than in controls in all countries (4.80+/-1.11 vs. 5.76+/-1.06 mmol/l in Czechs; 5.32+/-1.32 vs. 5.71+/-1.08 mmol/l in Lithuanians; 4.88+/-1.05 vs. 5.38+/-1.13 mmol/l in Kazakhs/Russians). Results from our study indicate substantial heterogeneity regarding major CVD risk factors in different populations with the exception of plasma total cholesterol which was inversely associated with ACS risk in all involved groups. These data reflect ethnical and geographical differences as well as changing pattern of cardiovascular risk profiles.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19030525
003      
CZ-PrNML
005      
20230725105155.0
007      
ta
008      
190830s2017 xr f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.933597 $2 doi
035    __
$a (PubMed)28379037
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Hubáček, Jaroslav, $d 1966- $7 nlk20050169367 $u Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
245    10
$a Traditional risk factors of acute coronary syndrome in four different male populations - total cholesterol value does not seem to be relevant risk factor / $c JA. Hubacek, V. Stanek, M. Gebauerova, V. Adamkova, V. Lesauskaite, D. Zaliaduonyte-Peksiene, A. Tamosiunas, A. Supiyev, A. Kossumov, A. Zhumadilova, J. Pitha
520    9_
$a Cardiovascular diseases are the most common cause of mortality and morbidity in most populations. As the traditional modifiable risk factors (smoking, hypertension, dyslipidemia, diabetes mellitus, and obesity) were defined decades ago, we decided to analyze recent data in patients who survived acute coronary syndrome (ACS). The Czech part of the study included data from 999 males, and compared them with the post-MONICA study (1,259 males, representing general population). The Lithuanian study included 479 male patients and 456 age-matched controls. The Kazakhstan part included 232 patients and 413 controls. In two countries, the most robust ACS risk factor was smoking (OR 3.85 in the Czech study and 5.76 in the Lithuanian study), followed by diabetes (OR 2.26 and 2.07) and hypertension (moderate risk elevation with OR 1.43 and 1.49). These factors did not influence the ACS risk in Kazakhstan. BMI had no significant effect on ACS and plasma cholesterol was surprisingly significantly lower (P<0.001) in patients than in controls in all countries (4.80+/-1.11 vs. 5.76+/-1.06 mmol/l in Czechs; 5.32+/-1.32 vs. 5.71+/-1.08 mmol/l in Lithuanians; 4.88+/-1.05 vs. 5.38+/-1.13 mmol/l in Kazakhs/Russians). Results from our study indicate substantial heterogeneity regarding major CVD risk factors in different populations with the exception of plasma total cholesterol which was inversely associated with ACS risk in all involved groups. These data reflect ethnical and geographical differences as well as changing pattern of cardiovascular risk profiles.
650    _2
$a akutní koronární syndrom $x krev $x diagnóza $x epidemiologie $7 D054058
650    _2
$a senioři $7 D000368
650    _2
$a cholesterol $x krev $7 D002784
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a rizikové faktory $7 D012307
651    _7
$a Česká republika $x epidemiologie $7 D018153 $2 czmesh
651    _7
$a Kazachstán $x epidemiologie $7 D007623 $2 czmesh
651    _7
$a Litva $x epidemiologie $7 D008097 $2 czmesh
655    _2
$a časopisecké články $7 D016428
700    1_
$a Staněk, Vladimír, $d 1933- $7 jn20000402271 $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Gebauerová, Marie $7 nlk20020114639 $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Adámková, Věra, $d 1954- $7 jx20050329003 $u Department of Preventive Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Lesauskaite, V. $u Institute of Cardiology, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania
700    1_
$a Zaliaduonyte-Peksiene, D. $u Department of Cardiology, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania
700    1_
$a Tamosiunas, A. $u Institute of Cardiology, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania
700    1_
$a Supiyev, A. $u Laboratory of Epidemiology and Public Health, Center for Life Sciences, National Laboratory Astana, Nazarbayev University, Astana, Kazakhstan
700    1_
$a Kossumov, A. $u Laboratory of Epidemiology and Public Health, Center for Life Sciences, National Laboratory Astana, Nazarbayev University, Astana, Kazakhstan
700    1_
$a Zhumadilova, A. $u Department of Biology, School of Science and Technology, Nazarbayev University, Astana, Kazakhstan
700    1_
$a Piťha, Jan, $d 1964- $7 mzk2003187379 $u Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic;
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 66, Supplementum 1 (2017), s. S121-S128
773    0_
$t Supplement on the occasion of the 85th European Atherosclerosis Society meeting : $g (2017), s. S121-S128 $w MED00200900
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28379037 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y 4 $z 0
990    __
$a 20190830 $b ABA008
991    __
$a 20230725105152 $b ABA008
999    __
$a ok $b bmc $g 1440161 $s 1069013
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 66 $c Supplementum 1 $d S121-S128 $e 2017Apr05 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
BMC    __
$a 2017 $d S121-S128 $m Supplement on the occasion of the 85th European Atherosclerosis Society meeting $x MED00200900
LZP    __
$b NLK118 $a Pubmed-20190830
Zpět

Najít záznam

Citační ukazatele

Možnosti archivace